Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

20123,272 citationsJournal Articlebronze Open Access

Authors

Jared M. Baeten · University of Washington

Deborah Donnell · University of Washington

Patrick Ndase

Nelly Mugo · Kenyatta National Hospital

James D. Campbell · Centers for Disease Control and Prevention

Jonathan Wangisi · The AIDS Support Organization

Jordan W. Tappero

Elizabeth A. Bukusi

Abstract

Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women. (Funded by the Bill and Melinda Gates Foundation; Partners PrEP ClinicalTrials.gov number, NCT00557245.).

Topics & Keywords

HIV/AIDS Research and Interventions HIV, Drug Use, Sexual Risk HIV Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 367, Issue 5, pp. 399-410

DOI: 10.1056/nejmoa1108524

Field-Weighted Citation Impact: 135.91